Answers are grounded in this paper and cite their sources.
Alterations in the genome that drive the transformation of normal cells into malignant cells program cancer initiation and progression. This rewiring also induces unique dependencies for genes and pathways that can be targeted therapeutically. Even though we have a clearer view of the spectrum of these molecular alterations, we still lack a complete understanding of how these alterations affect biological processes and create specific vulnerabilities in cancer cells. To address this, we have created the Cancer Dependency Map (DepMap) to systematically identify and map cancer vulnerabilities. Here, we provide an overview of the history and development of the current DepMap. We also highlight biological insights enabled by DepMap. Findings from DepMap will provide insights into new targets suitable for drug discovery efforts.
No takes yet. Share an insight, caveat, or question.
Arafeh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: